Caribou Biosciences (CRBU) Receivables (2020 - 2026)
Caribou Biosciences (CRBU) reported Receivables of $1.34 million for Q2 2026, down 34.0% from $2.03 million a year earlier and down 20.0% from the prior quarter.
Powered by 
Analysis
Caribou Biosciences (CRBU) Receivables (2020 - 2026) Analysis & Trends
At the end of FY2025, Caribou Biosciences posted Receivables of $1.97 million, down 5.7% from FY2024.
- Receivables has declined for four consecutive years, with a five-year compound annual growth rate of -12.4% (FY2020 to FY2025).
- By year, Receivables came in at $2.09 million in FY2024 (-14.0%), $2.43 million in FY2023 (-0.6%), $2.45 million in FY2022 (-63.1%) and $6.64 million in FY2021 (+73.2%).
- The Q2 2026 figure ranks as the lowest quarterly Receivables in data going back to Q4 2020.
- Year over year, Receivables has now declined in each of the last three quarters, with an average decline of 15.7% over the last eight quarters.
- The high point for year-over-year Receivables in five years was Q4 2021 (growth of 73.2%); the low point was Q4 2022 (a decline of 63.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.67 million (Q1 2026), $1.97 million (Q4 2025) and $2.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Caribou Biosciences | 44.30 Mn | -419.78 Mn | - | 1.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.17 Mn |
| Jun 30, 2026 | 1.34 Mn |
| Mar 31, 2026 | 1.67 Mn |
| Dec 31, 2025 | 1.97 Mn |
| Sep 30, 2025 | 2.07 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | 1.94 Mn |
| Mar 31, 2024 | 2.64 Mn |
| Dec 31, 2023 | 2.43 Mn |
| Sep 30, 2023 | 3.48 Mn |
| Jun 30, 2023 | 2.26 Mn |
| Mar 31, 2023 | 3.20 Mn |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 3.10 Mn |
| Jun 30, 2022 | 3.62 Mn |
| Mar 31, 2022 | 4.54 Mn |
| Dec 31, 2021 | 6.64 Mn |
API Access
Caribou Biosciences Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=CRBU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();